Now loading...
ICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals with a target price of Rs 1,265. The current market price is Rs 1365.9. Glenmark’s US prospects may improve from H2FY26. The company plans product launches and strategic initiatives to address supply and financial challenges in the coming years. They report a net profit of Rs 348.
Now loading...